Clinical trial intelligence topics

ALS

Validated public reports are available for this disease area.

Alzheimer's disease

Validated public reports are available for this disease area.

AML

Validated public reports are available for this disease area.

Obesity

Validated public reports are available for this disease area.

Type 2 Diabetes

Validated public reports are available for this disease area.

MASH / NASH

Validated public reports are available for this disease area.

Solid Tumors

Validated public reports are available for this disease area.

Breast Cancer

Validated public reports are available for this disease area.

Lung Cancer

Validated public reports are available for this disease area.

Multiple Myeloma

Validated public reports are available for this disease area.

Heart Failure

Validated public reports are available for this disease area.

Parkinson's Disease

Validated public reports are available for this disease area.

Atopic Dermatitis

Validated public reports are available for this disease area.

Asthma

Validated public reports are available for this disease area.

Major Depressive Disorder

Validated public reports are available for this disease area.

behavioral intervention

cell therapy

combination therapy

gene therapy

medical device

microbiome therapy

monoclonal antibody

protein therapy

RNA therapy

small molecule

vaccine

[225Ac]Ac-AKY-1189 (therapeutic), [64Cu]Cu-AKY-1189 (imaging)

1 drop of 0.375% SYL040012 (bamosiran), 1 drop of 0.750% SYL040012 (bamosiran), 1 drop of 1.125% SYL040012 (bamosiran), 1 drop of 1.5% SYL040012 (bamosiran), 1 drop of 0.5 % timolol maleate

18F-Florbetaben (Neuraceq®) PET/MRI

6% Bemotrizinol (BEMT)

a/LCI-OCT imaging probe, esophageal biopsy

AAV2-GDNF gene therapy for Parkinson's Disease

ABBV-101, Venetoclax

Abemaciclib, Abiraterone, Afatinib, Bevacizumab, Bicalutamide, Biospecimen Collection, Bortezomib, Cabazitaxel, Cabozantinib, Capecitabine, Carboplatin, Celecoxib, Cobimetinib, Copanlisib, Dabrafenib, Dacomitinib, Darolutamide, Dasatinib, Doxorubicin, Durvalumab, Enasidenib, Entrectinib, Enzalutamide, Erlotinib, Everolimus, Fluorouracil, Idelalisib, Imatinib, Ipilimumab, Lenvatinib, Leucovorin, Lorlatinib, Losartan, Nab-paclitaxel, Neratinib, Nivolumab, Olaparib, Oxaliplatin, Palbociclib, Panobinostat, Pembrolizumab, Pertuzumab, Ponatinib, Quality-of-Life Assessment, Regorafenib, Ruxolitinib, Sirolimus, Sorafenib, Sunitinib, Trametinib, Trastuzumab Emtansine, Tretinoin, Vemurafenib, Venetoclax, Vismodegib, Vorinostat

Ablative carbon dioxide laser therapy targeting vulvovaginal atrophy (VVA) and genitourinary syndrome of menopause (GSM) symptoms.

Acceptance and commitment therapy + app, Acceptance and commitment therapy

Acetaminophen

Acetaminophen, Ibuprofen

ACTIMMUNE

Acute Ischemic Stroke

Acute Lymphoblastic Leukaemia (ALL) treatment with a focus on risk stratification and innovative therapies including Inotuzumab ozogamicin and Blinatumomab.

Acute ST Elevation Myocardial Infarction

Adavosertib

Adenosine, Adenosine Mono Phosphate (AMP)

ADVAIR DISKUS 250/50 mg BID, SEREVENT 50 mcg BID

aerobic treadmill exercise

AGA2115

AGA2115, Placebo

AI-aided auscultation for respiratory sound classification

AKB-6548

Allogeneic pancreatic endoderm cells (PEC211) genetically modified using CRISPR/Cas9 to promote immune evasiveness and survival.

Almonertinib, chemotherapy

ALN-XDH, Placebo

ALT-803

Amantadine, Ribavirin, Oseltamivir, Oseltamivir

AMG 162 180 mg (SC) q 12 weeks, IV Bisphosphonate q 4 weeks, AMG 162- 180 mg q 4 weeks

AMG 355, Pembrolizumab

Aminohippurate Sodium Inj 20%, Iohexol Inj 300 milligrams per milliliter (MG/ML), PET/CT Scan

Amorphous Calcium Carbonate (ACC) as a potential adjunct therapy for Castrate Resistant Prostate Cancer (CRPC) with Bone Metastasis, focusing on skeletal health and pain management.

An abdominal binder

Androgen Receptor (AR) via PROTAC mechanism

Anemia associated with Chronic Kidney Disease

Anemia associated with Chronic Kidney Disease (CKD)

Anemia associated with chronic kidney disease in hemodialysis subjects

Anemia in Chronic Kidney Disease

Anemia in Chronic Kidney Disease (CKD)

Anemia in Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

Anemia in Hemodialysis Participants

Anemia in Hemodialysis Patients

Anemia in hemodialysis-dependent chronic kidney disease patients

Anemia of Chronic Kidney Disease in Pediatric Patients

Anemia secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)

Anomia therapy: semantic feature analysis and phonological components analysis;, Executive function training: computerized equipment

Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Artemether-Lumefantrine, Mefloquine- Artesunate

Askina Calgitrol paste

autologous fecal matter transplant

AVT03 (biosimilar to Denosumab)

AZD8233 subcutaneous injection, Placebo

B-cell Malignancies

B7H3 (CD276) - a target for antibody-drug conjugates (ADCs) and PROTACs in advanced prostate cancer.

Back Belief questionnaire, QUEBEC scale, Fear Avoidance beliefs questionnaire, Visual analog scale, individual interviews, Focus groups

Bacteriome and Mycobiome modulation in breast cancer patients

Bcl-xL (B-cell lymphoma-extra large) protein, a key anti-apoptotic protein involved in tumor cell survival.

BCL-XL protein (degradation via proteolysis-targeting chimera mechanism)

BCMA (B-cell maturation antigen), CD19, CD22, CD79